Dr. Baruch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin Street
Houston, TX 77030
Summary
- Dr. Erez Baruch is an oncologist in Houston, TX. Dr. Baruche received his medical degree from Tel Aviv University Sackler and has been in practice 10 years. Dr. Baruch specializes in melanoma. Dr. baruch has more than 20 publications and over 500 citings.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2022 - 2025- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2020 - 2022
Tel Aviv University SacklerClass of 2010
Certifications & Licensure
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Exploring unmet concerns in home hospice cancer care: Perspectives of patients, informal caregivers, palliative care providers, and family physicians.Eran Ben-Arye, Noah Samuels, Yael Keshet, Miri Golan, Erez Baruch
Palliative & Supportive Care. 2024-04-08 - 8 citationsInflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.Erez N Baruch, Priyadahrshini Nagarajan, Frederico O Gleber-Netto, Xiayu Rao, Tongxin Xie
Research Square. 2023-07-18 - 3 citationsMYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.Ettai Markovits, Ortal Harush, Erez N Baruch, Eldad D Shulman, Assaf Debby
Cancer Immunology Research. 2023-07-05
Press Mentions
Kanvas Bio Unveils Clinical Data on the Gut Microbiome’s Impact on Anti-Tumoral Immunity at SITCNovember 8th, 2024
Fecal Microbiota Transplants May Improve Resistance to Melanoma ImmunotherapyOctober 13th, 2021- Microbiome Transplants Can Reprogram Immune System to Attack TumorsJanuary 6th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
